相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Current State and Future Expectations of Translational Modeling Strategies to Support Drug Product Development, Manufacturing Changes and Controls: A Workshop Summary Report
Xavier J. H. Pepin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Impact of gastrointestinal physiology on drug absorption in special populations – An UNGAP review
Cordula Stillhart et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Using a Physiologically Based Pharmacokinetic Absorption Model to Establish Dissolution Bioequivalence Safe Space for Oseltamivir in Adult and Pediatric Populations
Lei Miao et al.
AAPS JOURNAL (2020)
Physiologically-based pharmacokinetic models for children: Starting to reach maturation?
Laurens F. M. Verscheijden et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Application of PBPK Modeling and Simulation for Regulatory Decision Making and Its Impact on US Prescribing Information: An Update on the 2018-2019 Submissions to the US FDA's Office of Clinical Pharmacology
Xinyuan Zhang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
State-of-the-Art Review on Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development
Venkata Yellepeddi et al.
CLINICAL PHARMACOKINETICS (2019)
Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous Moxifloxacin in Pediatric Patients: Dose Optimization in a Phase 1 Study
Heino Stass et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Predictive Pediatric Modeling and Simulation Using Ontogeny Information
Ibrahim Ince et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Model qualification of the PK-Sim® pediatric module for pediatric exposure assessment of CYP450 metabolized compounds
Yejin Esther Yun et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2019)
Bioequivalence Comparison of Pediatric Dasatinib Formulations and Elucidation of Absorption Mechanisms Through Integrated PBPK Modeling
Shruthi Vaidhyanathan et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Application of Physiologically-Based and Population Pharmacokinetic Modeling for Dose Finding and Confirmation During the Pediatric Development of Moxifloxacin
Stefan Willmann et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life
Jan-Frederik Schlender et al.
CLINICAL PHARMACOKINETICS (2018)
Regorafenib: A Review in Metastatic Colorectal Cancer
Sohita Dhillon
DRUGS (2018)
Moxifloxacin in Pediatric Patients With Complicated Intra-abdominal Infections: Results of the MOXIPEDIA Randomized Controlled Study
Stefan Wirth et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2018)
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study
Stefan Willmann et al.
THROMBOSIS JOURNAL (2018)
Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension
Tian-Yu Lian et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Assessment of Age-Related Changes in Pediatric Gastrointestinal Solubility
Anil R. Maharaj et al.
PHARMACEUTICAL RESEARCH (2016)
Using Physiologically Based Pharmacokinetic (PBPK) Modelling to Gain Insights into the Effect of Physiological Factors on Oral Absorption in Paediatric Populations
Angela Villiger et al.
AAPS JOURNAL (2016)
Pharmacokinetics and Safety of Macrocyclic Gadobutrol in Children Aged Younger Than 2 Years Including Term Newborns in Comparison to Older Populations
Christian Kunze et al.
INVESTIGATIVE RADIOLOGY (2016)
Analysis of pharmacokinetics of Gd-DTPA for dynamic contrast-enhanced magnetic resonance imaging
Saeid Taheri et al.
MAGNETIC RESONANCE IMAGING (2016)
Population pharmacokinetics and the pharmacokinetic/pharmacodynamic relationship of riociguat in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Soundos Saleh et al.
PULMONARY CIRCULATION (2016)
Phase I dose-escalation and pharmacokinetic (PK) study of regorafenib in pediatric patients with recurrent or refractory solid malignancies.
Birgit Geoerger et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model
L. Kuepfer et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
Development of a Physiologically-Based Pharmacokinetic Model for Preterm Neonates: Evaluation with In Vivo Data
Karina Claassen et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Development of a Paediatric Population-Based Model of the Pharmacokinetics of Rivaroxaban
Stefan Willmann et al.
CLINICAL PHARMACOKINETICS (2014)
Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development
A. R. Maharaj et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2014)
A Workflow Example of PBPK Modeling to Support Pediatric Research and Development: Case Study with Lorazepam
A. R. Maharaj et al.
AAPS JOURNAL (2013)
Regulatory Experience With Physiologically Based Pharmacokinetic Modeling for Pediatric Drug Trials
R. Leong et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part II: Extension to describe performance of solid dosage forms
Kirstin Thelen et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Evolution of a Detailed Physiological Model to Simulate the Gastrointestinal Transit and Absorption Process in Humans, Part 1: Oral Solutions
Kirstin Thelen et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor
Dagmar Kubitza et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Metabolism and Excretion of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Rats, Dogs, and Humans
C. Weinz et al.
DRUG METABOLISM AND DISPOSITION (2009)
Pharmacokinetics and Safety of Gadobutrol-Enhanced Magnetic Resonance Imaging in Pediatric Patients
Gabriele Hahn et al.
INVESTIGATIVE RADIOLOGY (2009)
Determination of amikacin in cerebrospinal fluid by high-performance liquid chromatography with pulsed electrochemical detection
Gordana Brajanoski et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
Fluoroquinolone efflux mediated by ABC transporters
Ana I. Alvarez et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Organic anion transporter 3 (Oat3/Slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin
Adam L. VanWert et al.
MOLECULAR PHARMACOLOGY (2008)
A mechanistic approach for the scaling of clearance in children
Andrea N. Edginton et al.
CLINICAL PHARMACOKINETICS (2006)
Development and evaluation of a generic physiologically based pharmacokinetic model for children
Andrea N. Edginton et al.
CLINICAL PHARMACOKINETICS (2006)
Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism
MT Granfors et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Effects of co-administration of ibuprofen-lysine on the pharmacokinetics of amikacin in preterm infants during the first days of life
K Allegaert et al.
BIOLOGY OF THE NEONATE (2004)
Nonparametric population pharmacokinetic analysis of amikacin in neonates, infants, and children
JM Tréluyer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
分享论文
